RESULTS The Effect of Lutein on Chicken Body Weight and Leg Muscle Fiber Morphology We compared body weight differences between the 2 groups of chickens and found that, although the lutein group showed a trend of increased body weight, the difference was not significant ( P > 0.05; Figure 1 A).
While E2 levels in the Ctr-T group showed a trend toward lower levels than the Sham group, this difference was not statistically significant ( P > 0.05).
While there was no clear dependence between the measured relaxation time constants and the blood pH, measurements with 25 mM hyperpolarized [1- 13 C]pyruvate containing 26.6 μM OX063 radical showed a trend towards a correlation between blood pH ( r = −0.62, p > 0.05) and the T 2 relaxation time constant.
Adenine intake decreased the diversity and separated microbiota structure Chao1, Observed_species, and Shannon indexes were significantly lower in the NMM group compared with the NC group ( P < 0.05; P < 0.05; P < 0.05), and the above indexes showed a trend of reduction in the NML group ( P > 0.05; P > 0.05; P > 0.05) ( Fig. 4 A–C), suggesting that 50 mg/(kg·d) adenine intake markedly reduced diversity of gut content microbiota of mice.
Valerate production showed a trend ( p = 0.05) for treatments with different levels of post-ruminal urea, with higher values when a higher percentage of post-ruminal urea was used.
The litter C:N ratio showed a trend of decreasing and then increasing with increasing sampling time at 6 and 10 years of recovery, and the value in October was markedly ( P< 0.05) greater than that in May ( Figure 5B ).
When comparing the different clinical groups of the PH patients, only LVEF showed a trend of difference, mainly driven by the decreased values in the PH group 2 and group 2/3 ( p = 0.050). 3.2.
In the EB stage, all P2Y receptors showed a trend for increased expression, with the most significant increase observed for P2Y 2 and P2Y 6 receptors compared with hESCs (P<0.05).
Vice versa, after 8 weeks, cardiac masses, volumes, and output showed a trend for lower values in sham operated rats compared to controls in absolute measures (782.2±57.2/260.2±33.2 vs. 805.9±84.8/310.4±48.5 mg, p<0.05 for left/right ventricular mass), but not normalized to body weight.
In addition, they showed a trend effect for up-regulation of genes implicated in GABA synthesis: GLS (p = 0.050) and GAD1 (p = 0.050) and significant down-regulation of ABAT (p = 0.030) that plays a role in GABA metabolism.
Among the 10 platinum agent assays, 2 assays (Oxaliplatin 1, Cisplatin 1) showed a trend of higher AUCs in cell lines with BRCA alterations (unadjusted P < 0.05, adjusted P ≧ 0.05), while no assays showed lower AUCs.
Animals receiving a high fat diet without inhalation treatment showed a trend of higher adipose tissue compared to the others ( p > 0.05) ( Figure 3 ).
Four metabolites showed a trend toward overabundance in LAM samples (Mann–Whitney test; P < 0.05) and were subsequently analyzed in plasma from an additional set of 30 LAM patients (Appendix Table S2 ), 12 healthy age‐matched female controls, as well as samples from women with LAM‐related pulmonary diseases, the latter group comprising 10 individuals diagnosed with Langerhans cell histiocytosis, 10 with Sjögren syndrome, seven with emphysema, and three with systemic lupus erythematosus.
Although there were no significant ( P <0.05, Bonferroni correction) differences in the FNCs of the NC and aMCI patients or the MCI and AD patients, AD patients showed a trend toward decreased ( P <0.05, uncorrected) FNC between the aDMN and pDMN compared to the aMCI patients.
Results First, as regards cannabis effects, our data showed a trend towards more severe positive symptoms (PANSS, p = 0.05) and better performance in manipulative abilities (matrix test-WAIS, p = 0.041) among cannabis users compared to non-users.
Compared to the model group, the LF-EA group showed a decreasing trend in uterine mass ( P > 0.05), while the HF-EA group demonstrated reductions in uterine mass ( P < 0.05), both the LF-EA group and the HF-EA group showed a trend towards reduced uterine index, transverse diameter of the uterine horns, kidney index, and ovary index ( P > 0.05).
Our next analysis suggested that metronidazole treatment in CDI is significantly associated with a lower recurrence rate ( p = 0.001), while it also showed a trend toward improved outcomes and reduced mortality, although these associations were borderline significant ( p = 0.050).
Ultimately, LLII MOTS-c treatment showed a trend towards increased median (6.4%) and maximum (7.0%) lifespan and reduced hazard ratio (0.654); P = 0.05 until 31.8 months (Fig. 4m ).
Average root diameter (RD) showed a trend of small pot > large pot > medium pot, with no significant difference between the large and small pot treatments ( p < 0.05).
BOP showed a trend toward reduction in the omega-3 group, although the confidence intervals crossed the null value, and heterogeneity emerged at three months ( p < 0.05) ( Figure 11 A,B).
Regarding fibrosis indicators, although PCSK9i use showed a trend toward improvement in Δ APRI (β = −0.021) and Δ FIB-4 (β = −0.19), these associations did not reach statistical significance in the adjusted model ( P > 0.05).
The other regions showed a trend towards indicator stability (p > 0.05).
The need for an Extraventricular Drainage (EVD) showed a trend toward a correlation with the development of infarctions ( p = 0.05, OR = 4.12, 95% CI = 0.96–17.7).
The analysis revealed that while the SP group showed a trend toward higher median Shannon and Simpson indices compared to the CAP group, these differences did not reach statistical significance ( p > 0.05).
Administration at 6 h showed a trend toward longer survival ( p = 0.050), whereas administration at 12 h resulted in shorter survival compared with concurrent treatment (Fig. 5 c).